Literature DB >> 32710314

Diagnosis and Treatment of Breast Cancer in the Precision Medicine Era.

Jing Yan1, Zhuan Liu1, Shengfang Du2, Jing Li1, Li Ma1, Linjing Li3.   

Abstract

Breast cancer is one of the most leading causes of death for women worldwide. According to statistics published by the International Agency for Research on Cancer (IARC), the incidence of breast cancer is on the rise year by year in most parts of the world. The existence of heterogeneity limits the early diagnosis and targeted therapy of breast cancer. Nowadays, precision medicine brings a new perspective to personalized diagnosis and targeted therapy, overcomes the heterogeneity of different patients, and provides an opportunity for screening of high-risk populations. As a clinician, we are committed to using genomic to provide a favorable perspective in the field of breast cancer. The current review describes the recent advances in the understanding of precision medicine for breast cancer in the aspect of the genomics which could be applied to improve our ability to diagnose and treat breast cancer individually and effectively.

Entities:  

Keywords:  Breast cancer; Genomics; Precision medicine; Prevention; Treatment

Mesh:

Year:  2020        PMID: 32710314     DOI: 10.1007/978-1-0716-0904-0_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Persistence with tamoxifen and aromatase inhibitors in Germany: a retrospective cohort study with 284,383 patients.

Authors:  Niklas Gremke; Sebastian Griewing; Saket Chaudhari; Swati Upadhyaya; Ivan Nikolov; Karel Kostev; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-23       Impact factor: 4.322

2.  Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred.

Authors:  Rebeca Font; Maria Buxó; Alberto Ameijide; José Miguel Martínez; Rafael Marcos-Gragera; Marià Carulla; Montse Puigdemont; Mireia Vilardell; Sergi Civit; Gema Viñas; Josep A Espinàs; Jaume Galceran; Ángel Izquierdo; Josep M Borràs; Ramon Clèries
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

3.  Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.

Authors:  Babak Mamnoon; Jagadish Loganathan; Matthew I Confeld; Nimesha De Fonseka; Li Feng; Jamie Froberg; Yongki Choi; Daniel M Tuvin; Venkatachalem Sathish; Sanku Mallik
Journal:  ACS Appl Bio Mater       Date:  2020-12-23

4.  Impact of Ultrasound-Guided Deep Serratus Anterior Plane Block Combined With Dexmedetomidine as an Adjuvant to Ropivacaine Inpatient Quality of Recovery Scores Undergoing Modified Radical Mastectomy: A Randomized Controlled Trial.

Authors:  Yu Wu; Yuling Kang; Yanli Li; Bohan Fu
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

5.  Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients.

Authors:  Yingkun Xu; Yang Peng; Meiying Shen; Li Liu; Jinwei Lei; Shun Gao; Yuan Wang; Ailin Lan; Han Li; Shengchun Liu
Journal:  J Oncol       Date:  2022-04-20       Impact factor: 4.501

Review 6.  Locoregional Surgery in Metastatic Breast Cancer: Do Concomitant Metabolic Aspects Have a Role on the Management and Prognosis in this Setting?

Authors:  Maria Ida Amabile; Federico Frusone; Alessandro De Luca; Domenico Tripodi; Giovanni Imbimbo; Silvia Lai; Vito D'Andrea; Salvatore Sorrenti; Alessio Molfino
Journal:  J Pers Med       Date:  2020-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.